GLRX and fatty liver disease: However, male GRX1 KO mice on a C57BL/6NJ background develop obesity, hyperlipidemia, and hepatic steatosis by 8 months of age [103], suggesting a more complex mechanism by which sex differences affect the metabolic phenotype induced by GRX1 deficiency.